MARgenomics

GINYS-IMIM-006
Montserrat Torà Barnadas
Platform mainly aimed at translational research that integrates all phases of the genomic analysis process: from the initial phase of project advice, through the processing of samples, to the final analysis of data and support to the interpretation of the results.  

Services

MARGenomics offers a wide range of services integrating all phases of a genomic analysis process, from the initial phase of project advice, to the final analysis of the data, the validation of the results and the expert support in the its interpretation.

Advice on experimental design
DNA and / or RNA extraction in different types of samples (whole blood, frozen or paraffined tissue, etc.)
DNA / RNA quality analysis (Quantification and Integrity)
  • Quantification of DNA or RNA by fluorimetry and / or spectrophotometry
  • DNA integrity analysis with agarose gels and / or Bioanalyzer
  • RNA Integrity Analysis by Bioanalyzer
Real-time quantitative PCR (qPCR)
Microarrays
  • Expression
    Genomics
Next Generation sequencing (Library preparation and processing on appropriate platforms)
  • Whole Genome sequencing
  • Exome sequencing
  • RNA sequencing
  • Small RNA sequencing
  • Panel sequencing
  • ChIP sequencing
  • Bisulfite sequencing
Data analysis
  • Sequence alignment
  • Variant Calling and Copy Number analysis from genomic data
  • Identification of differentially expressed genes, alternative splicing and fusion genes in transcriptomic data
  • Study of smallRNAs through microtranscriptome analysis.
  • Identification of regions with peak protein-DNA interaction in chromatin immunoprecipitation sequencing experiments (ChIP-seq)
  • Identification of positions or regions of methylated DNA in methyloma data
  • Integration of data from different omic platforms using specific methodology
  • Microarray analysis
  • QPCR analysis

Staff

Montserrat Torà Barnadas | mtora@imim.es | ORCID | PRC Page

Publications

Lamin B1 mapping reveals the existence of dynamic and functional euchromatin lamin B1 domains
Laura Pascual-Reguant, Enrique Blanco, Silvia Galan, François Le Dily, Yasmina Cuartero, Gemma Serra-Bardenys, Valerio Di Carlo, Ane Iturbide, Joan Pau Cebrià-Costa, Lara Nonell, Antonio García de Herreros, Luciano Di Croce, Marc A. Marti-Renom & Sandra Peiró
Nature Communications volume 9, Article number: 3420 (2018)
Transcriptome and cytogenetic profiling analysis of matched in situ/invasive cutaneous squamous cell carcinomas from immunocompetent patients
Irene García-Díez, Inmaculada Hernández-Muñoz, Eugenia Hernández-Ruiz, Lara Nonell, Eulàlia Puigdecanet, Marta Bódalo-Torruella, Evelyn Andrades, Ramon M Pujol, Agustí Toll
Genes Chromosomes Cancer . 2019 Mar;58(3):164-174. doi: 10.1002/gcc.22712. Epub 2019 Jan 7
Expression profiling of microRNAs in human bone tissue from postmenopausal women
Laura De-Ugarte, Jenny Serra-Vinardell, Lara Nonell, Susana Balcells, Magdalena Arnal, Xavier Nogues, Leonardo Mellibovsky, Daniel Grinberg, Adolfo Diez-Perez, Natalia Garcia-Giralt
Hum Cell . 2018 Jan;31(1):33-41. doi: 10.1007/s13577-017-0181-y. Epub 2017 Sep 20.
Feasibility of the AML profiler (Skyline™ Array) for patient risk stratification in a multicentre trial: a preliminary comparison with the conventional approach
Josep F Nomdedéu, Eulalia Puigdecanet, Elena Bussaglia, Juan José Hernández, Maite Carricondo, Camino Estivill, Josep Maria Martí-Tutusaus, Mar Tormo, Lurdes Zamora, Elena Serrano, Granada Perea, Maria Paz Queipo de Llano, Antoni García, Isabel Sánchez-Ortega, Josep Maria Ribera, Lara Nonell, Anna Aventin, Francesc Solé, Maria Salut Brunet, Jorge Sierra
Hematol Oncol . 2017 Dec;35(4):778-788. doi: 10.1002/hon.2304.
FOXO1 down-regulation is associated with worse outcome in bladder cancer and adds significant prognostic information to p53 overexpression
Josep Lloreta, Alba Font-Tello, Núria Juanpere, Albert Frances, Marta Lorenzo, Lara Nonell, Silvia de Muga, Ivonne Vázquez, Lluís Cecchini, Silvia Hernández-Llodrà
Hum Pathol . 2017 Apr;62:222-231.

INSTITUTE

IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

Parc de Recerca Biomèdica de Barcelona (PRBB)
Dr. Aiguader, 88, 1r pis, despatx 153

08003 Barcelona http://www.imim.es/

DOMAINS RIS3CAT

  • Education and knowledge generation system
  • Industrial system
  • Socio-sanitary system

CATEGORIES

  • TECHNOLOGICAL EQUIPMENT
    • Genomics
    • Sequencing

RATES AND ACCESS

Availability Level: Medium
Access Procedures:

Open

MARGenomics Request

To request information, to plan an experiment or before requesting services, please contact the MARGenomics secretariat: margenomics@imim.es

QUALITY CONTROL

ISO 9001 – Quality Management
ISO 9001 sets out the criteria for a quality management system. This standard is based on a number of quality management principles that include a strong customer focus, motivation and involvement of senior management, process focus, and continuous improvement. The use of the ISO 9001 standard helps to ensure that customers receive consistent and good quality products and services, which in turn brings many business benefits.
Status: Active

FACILITIES NETWORKS

INB – Bioinformatics Platform
Provide world-class basic bioinformatics resources to the national and international life sciences research community in key fields such as functional genomics, RNA-Seq transcriptomics, genotyping, genomic medicine, and molecular dynamics simulations. Provide a platform for integrated basic bioinformatics services to the research community. Facilitate the coordinated participation of bioinformatics groups in large-scale national and international projects that require and benefit from closely collaborating teams that are known and accustomed to working together.
Reach: Spain
Status: Active
CERCA - Ginys